Scholarlink

<p>ADP ribosylation factor like 4c (Arl4c), a member of the small GTPase superfamily, has been implicated in tumor progression in various human cancers.&#xa0;However, its role in canine cancers remains largely unexplored. In this study, we demonstrated that Arl4c exhibits significant oncogenic activity in canine melanoma. Immunohistochemical analysis of canine clinical tumor samples indicated that Arl4c is highly expressed in canine melanoma. Functional assays in canine melanoma cell lines showed that Arl4c overexpression promotes cell proliferation and migration. Furthermore, a&#xa0;bioinformatics analysis identified a novel association between Arl4c and the nuclear factor kappa B (NF-κB) signaling pathway, subsequent experimental validation using Western blotting and real-time quantitative polymerase chain reaction&#xa0;(RT-qPCR) confirmed that Arl4c positively regulates NF-κB pathway activation, linking it to key tumorigenic mechanisms. These findings establish Arl4c as a pro-tumorigenic factor in canine melanoma and underscore its potential as both a diagnostic biomarker and a therapeutic target in veterinary oncology. Our study not only highlights Arl4c's role in canine tumorigenesis, but also reinforces the value canine models for informing novel treatment strategies for human cancers.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Functional analysis of Arl4c reveals its role in canine melanoma proliferation and migration

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月22日

查看全文
  • Zeyun Zhu,
  • Siying Wang,
  • Rifei Li,
  • Chao Song,
  • Yipeng Jin,
  • Gebin Li,
  • Jun Tang

摘要

ADP ribosylation factor like 4c (Arl4c), a member of the small GTPase superfamily, has been implicated in tumor progression in various human cancers. However, its role in canine cancers remains largely unexplored. In this study, we demonstrated that Arl4c exhibits significant oncogenic activity in canine melanoma. Immunohistochemical analysis of canine clinical tumor samples indicated that Arl4c is highly expressed in canine melanoma. Functional assays in canine melanoma cell lines showed that Arl4c overexpression promotes cell proliferation and migration. Furthermore, a bioinformatics analysis identified a novel association between Arl4c and the nuclear factor kappa B (NF-κB) signaling pathway, subsequent experimental validation using Western blotting and real-time quantitative polymerase chain reaction (RT-qPCR) confirmed that Arl4c positively regulates NF-κB pathway activation, linking it to key tumorigenic mechanisms. These findings establish Arl4c as a pro-tumorigenic factor in canine melanoma and underscore its potential as both a diagnostic biomarker and a therapeutic target in veterinary oncology. Our study not only highlights Arl4c's role in canine tumorigenesis, but also reinforces the value canine models for informing novel treatment strategies for human cancers.